Cpt1 expressing yeast strains

Saccharomyces cerevisiae expressing under the GAL promoter either the wild-type rat liver CPT1, mutated rat liver CPT1 or chimeric CPT. CPT1A activity is inhibited by malonyl-CoA, its allosteric inhibitor.

Interest / Relevance: Allow to have isolated mitochondria with wild-type rat liver CPT1 (active and sensitive to malonyl-CoA inhibition) or mutated CPT1 (for example, active but insensitive to malonyl-CoA inhibition). These mitochondria could be used as biological material for screening chemical molecules able to modulate CPT1 activity and malonyl-CoA sensitivity.
Scientist's name: Carina PRIP-BUUS
Publications:
Cohen I et al. (1998) J. Biol. Chem. 273 : 29896-29904.rnCohen I et al. (2001) J. Biol. Chem. 276 : 5403-5411. rnFaye A et al. (2007) J. Biol. Chem. 282 : 26908-16. rnFaye A et al. (2005) Biochem. J. 387 : 67-76.

Reference:

RT00005

Business Developper
contact
Inserm Transfert
Research Tools
Organism: Saccharomyces cerevisiae
Tissue: Unicellular
Morphology: Not relevant
Passage Number: Not relevant
Subculture Routine: Not relevant
Culture Medium: Minimal selective medium. Induction of protein expression by addition of galactose
Growth Properties: Not relevant
Karyotype: Not relevant
Rare disease: No
Last update: 08/07/2024

You might also be interested in